5mg Cycloastragenol Plant Description
Astragalus Root, Chinese name Huang Qi, is an herb from traditional Chinese medicine (TCM) which is traditionallyused for its immune enhancing properties, but is also recommended in TCM for “deficiency of chi” (life force) ̈C which might include symptoms such aslack of energy and fatigue. The plant is native to Northern China and Mongoliaand there are over 2,000 types of astragalus worldwide.
Cycloastragenol extracted and purified from the roots of Astragalus membranaceus, It is similar structure to the Astragaloside IV molecule but smaller and more bioavailable. Cycloastragenol is being claimed to stimulate immune system, to improve cardiovascular health, to repair DNA, and to activate telomerase that is crucial for anti-aging.
RDHealthIngredients offer high quality cycloastragenol factory supply with premium cycloastragenol content, pure and natural, lower solvent residual, ETO free, PAHS qualified from The third party test.
SCIENTIFIC EVIDENCE
- CLINICAL STUDIES DEMONSTRATE
- Stimulate the Immune System
- Improve cardiovascular health
- Anti-aging
- KEY BENEFITS
- Wellness
- Sports
- Cosmetics
- Cognitive health
- safeguard the immune system,
- antibacterial, and anti inflammatory,
- encourages DNA to repair damages by initiating telomerase and allow the nuclear protease catalyzed the synthesis and growth of telomere DNA.
PRODUCT FEATURES
- BOTANICAL ORIGIN Astragalus membranaceus (roots)
- BIOACTIVES Cycloastragenol 99%
- CAS No. 78574-94-4
- CULTIVATED OR WILD Wild-crafted in mongolia and Shanxi
- APPEARANCE White fine powder
- TASTE Astringent
- SOLUBILITY not water soluble
- SAFETY & QUALITY GMO free, BSE/TSE free, allergen free
- PACKAGING MATERIAL 5/ 10/100g per aluminum foil bag/Fiber Drum
- PRODUCT CERTIFICATION Kosher, Halal
- RECOMMENDED SERVING 5mg
REFERENCES
- Zhang S, Lu J, Yan J, Zhang H. Research progress of preparation technology and pharmacological effect of cycloastragenol. Chin J New
Drugs. 2016;16:1872–1875. - Szabo NJ. Dietary safety of cycloastragenol from Astragalus spp: Subchronic toxicity and genotoxicity studies. Food Chem Toxicol. 2014;64:322–334. doi: 10.1016/j.fct.2013.11.041.
- Meng JJ, Li SP, Zhao FY, Tong Y, Mu DZ, Qu Y. Effect of telomerase activation on biological behavior of neural stem cells in hypoxic-ischemic rats. Zhongguo Dang Dai Er Ke Za Zhi. 2017;19:229–36.
- Li J. Astragaloside IV and cycloastragenol attenuate osteoblastic injury and aging elicited by oxidative stress. 2017
- Yung LY, Lam WS, Ho MK, Hu Y, Ip FC, Pang H, Chin AC, Harley CB, Ip NY, Wong YH. Astragaloside IV and cycloastragenol stimulate the phosphorylation of extracellular signal-regulated protein kinase in multiple cell types. Planta Med. 2012;78:115–121. doi: 10.1055/s-0031-1280346.
Are you looking for certified origin, traceability or safety? We propose a full range of titrated extract, Astragalus Root Extract in accordance with GB, USP, EP, Pls find the list here. If not listed, please get contact with us at sales06@health-ingredients.com.
Or you can search them by A-Z Product List.
TA-65, as a complex extract, contains Cycloastragenol but also includes other astragalosides and compounds from the root. The manufacturer posits that this specific blend of compounds may have a synergistic effect, potentially enhancing the bioavailability or efficacy beyond what isolated Cycloastragenol can achieve alone. This leads to a major practical difference: cost and accessibility. TA-65 is a premium-priced product, often available through specific channels and accompanied by clinical consultations. In contrast, generic Astragalus Root Extract supplements are generally more accessible and affordable for the broader consumer market.
In conclusion, Astragalus Root Extract Pure Cycloastragenol and TA-65 are inextricably linked yet distinct. Cycloastragenol is the active molecular hero derived from the Astragalus root, while TA-65 is a specific, branded vehicle for its delivery. The choice between a purified Astragalus Root Extract supplement and the proprietary TA-65 complex ultimately hinges on a consumer’s or practitioner’s preference for a single-molecule approach versus a patented blend, balanced against considerations of cost, available evidence, and desired level of clinical support.